Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

Priscilla A. Hollander; Wendy L. Carofano; Raymond L.H. Lam; Gregory T. Golm; Roy Eldor; Michael F. Crutchlow; Michael C. Marcos; Marc S. Rendell; Philip D. Home; Baptist Gallwitz; Julio Rosenstock

doi:10.1111/dom.13363

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13363 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2229-2237 ◽

Cited By ~ 4

Author(s):

Priscilla A. Hollander ◽

Wendy L. Carofano ◽

Raymond L.H. Lam ◽

Gregory T. Golm ◽

Roy Eldor ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Efficacy And Safety ◽

Open Label

Download Full-text

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12674 ◽

2016 ◽

Vol 18 (8) ◽

pp. 803-811 ◽

Cited By ~ 14

Author(s):

L. Zang ◽

Y. Liu ◽

J. Geng ◽

Y. Luo ◽

F. Bian ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Active Comparator

Download Full-text

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

Diabetes Care ◽

10.2337/dc12-1333 ◽

2012 ◽

Vol 36 (5) ◽

pp. 1368-1376 ◽

Cited By ~ 46

Author(s):

M. Davies ◽

S. Heller ◽

S. Sreenan ◽

H. Sapin ◽

O. Adetunji ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Detemir ◽

Efficacy And Safety ◽

Open Label ◽

Daily Insulin

Download Full-text

Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in J apanese patients with type 2 diabetes: a randomized, open‐label, phase III , non‐inferiority study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12540 ◽

2015 ◽

Vol 17 (10) ◽

pp. 994-1002 ◽

Cited By ~ 50

Author(s):

E. Araki ◽

N. Inagaki ◽

Y. Tanizawa ◽

T. Oura ◽

M. Takeuchi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily ◽

Daily Insulin ◽

Open Label Phase

Download Full-text

Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)

Advances in Therapy ◽

10.1007/s12325-019-00951-4 ◽

2019 ◽

Vol 36 (6) ◽

pp. 1485-1496 ◽

Cited By ~ 1

Author(s):

LiNong Ji ◽

LiMing Chen ◽

YanGang Wang ◽

ZhongShu Ma ◽

XingWu Ran ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Parallel Group ◽

Free Insulin ◽

Blood Glucose Concentrations

Download Full-text

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial

Diabetes Care ◽

10.2337/dc19-2452 ◽

2020 ◽

Vol 43 (6) ◽

pp. 1249-1257

Author(s):

Hirotaka Watada ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Yasuhiro Hashimoto ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Decision letter for "Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulfonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, phase 3 trial"

10.1111/dom.13981/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Parallel Design ◽

Open Label Phase

Download Full-text

Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study

Endocrine Journal ◽

10.1507/endocrj.ej18-0309 ◽

2019 ◽

Vol 66 (11) ◽

pp. 971-982 ◽

Cited By ~ 3

Author(s):

Jun Suzuki ◽

Tadashi Yamakawa ◽

Mari Oba ◽

Jo Nagakura ◽

Erina Shigematsu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Meal Time ◽

Bolus Insulin

Download Full-text

Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2015.09.015 ◽

2015 ◽

Vol 110 (2) ◽

pp. 158-165 ◽

Cited By ~ 10

Author(s):

María S. Ruiz de Adana ◽

Natalia Colomo ◽

Cristina Maldonado-Araque ◽

María I. Fontalba ◽

Francisca Linares ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Respiratory Disease ◽

Basal Insulin ◽

Glucose Monitoring ◽

Efficacy And Safety ◽

Nph Insulin

Download Full-text

Review for "Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulfonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, phase 3 trial"

10.1111/dom.13981/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Parallel Design ◽

Open Label Phase

Download Full-text

Author response for "Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulfonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, phase 3 trial"

10.1111/dom.13981/v2/response1 ◽

2020 ◽

Author(s):

Tina Vilsbøll ◽

Ella Ekholm ◽

Eva Johnsson ◽

Ricardo Garcia‐Sanchez ◽

Nalina Dronamraju ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Author Response ◽

Efficacy And Safety ◽

Open Label ◽

Phase 3 ◽

Parallel Design ◽

Open Label Phase

Download Full-text